4.6 Letter

ITP definitions: Time for an update

Related references

Note: Only part of the references are listed.
Review Hematology

Novel therapies for immune thrombocytopenia

David J. Kuter

Summary: Current therapies for ITP are successful in most patients, but some require new approaches. Novel therapies focus on reducing anti-platelet antibody production or inhibiting the phagocytic system to decrease platelet destruction.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Hematology

Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: Communication from the ISTH SSC subcommittee on platelet immunology

Hanny Al-Samkari et al.

Summary: Despite prior attempts to standardize ITP outcome evaluation, wide variability in platelet, bleeding, and HRQoL outcomes remain. Most ITP studies did not systematically evaluate bleeding or HRQoL outcomes. Further standardization of outcome measurement in both pediatric and adult ITP is greatly needed.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Hematology

American Society of Hematology 2019 guidelines for immune thrombocytopenia

Cindy Neunert et al.

BLOOD ADVANCES (2019)